Dr. Dan

Dendreon's Provenge Is Scientifically Intriguing but Commercially Nonsensical

As others have pointed out, this author is either deliberately misrepresenting the data or, as seems more likely to me, confused about terms like "median" and "survival". He also either didn't understand or forgot to mention that the patient test population had cancer that had ALREADY spread beyond the prostrate, and had ALREADY failed to respond to all available treatments. THAT was the placebo group. To prove that among this population significantly more people were alive after 3 years with Provenge is not just good - it's amazing.